Corient Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Corient Capital Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$309K	Buy	2,944 +350	+13%	+$38.4K	0.02%	451
2022 Q2	$272K	Sell	2,594 -713	-22%	-$84.6K	0.02%	507
2022 Q1	$423K	Buy	3,307 +982	+42%	+$118K	0.03%	422
2021 Q4	$287K	Buy	2,325 +64	+3%	+$8.38K	0.02%	541
2021 Q3	$321K	Sell	2,261 -496	-18%	-$73K	0.02%	473
2021 Q2	$431K	Buy	2,757 +217	+9%	+$35.2K	0.03%	395
2021 Q1	$395K	Buy	2,540 +303	+14%	+$46.9K	0.03%	371
2020 Q4	$335K	Buy	2,237 +268	+14%	+$37.9K	0.03%	350
2020 Q3	$260K	Sell	1,969 -14	-0.7%	-$1.83K	0.03%	375
2020 Q2	$230K	Buy	+1,983	New	+$229K	0.03%	400
2020 Q1	–	Sell	-2,357	Closed	-$342K	–	497
2019 Q4	$342K	Buy	2,357 +87	+4%	+$12K	0.04%	333
2019 Q3	$303K	Buy	+2,270	New	+$293K	0.04%	343

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Corient Capital Partners's ZBH Position: Q3 2022 in Review

Corient Capital Partners increased its Zimmer Biomet (ZBH) stake by 13% in Q3 2022, buying an estimated $38.4K and bringing the position to 2,944 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #451.

Corient Capital Partners first reported a position in ZBH in Q3 2019 and has held it in 12 quarters since. The position peaked at $431K in Q2 2021. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Corient Capital Partners held 2,944 shares of Zimmer Biomet worth $309K as of Q3 2022.
Corient Capital Partners bought 350 Zimmer Biomet shares in Q3 2022, an estimated $38.4K.
Zimmer Biomet made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #451 holding.
Corient Capital Partners first reported a position in Zimmer Biomet in Q3 2019 and has held it in 12 quarters since.
Corient Capital Partners's Zimmer Biomet position peaked at $431K in Q2 2021.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.